George Migausky - Dyax Corp CFO, Principal Accounting Officer and Executive VP

CFO

Mr. George V. Migausky is Chief Financial Officer and Executive Vice President of Dyax Corporationration since 2008. Prior to joining Dyax he served as CFO of Wellstat Management Company a privatelyheld company responsible for the strategy business development and operations of an affiliated group of five life science companies. From 1990 to 2004 Mr. Migausky served as CFO at IGEN International where he was instrumental in preparing the Company for its initial public offering in 1994 its merger with F. Hoffman La Roche in 2004 and the simultaneous spinoff of BioVeris Corporation as an independent public company. He then served as CFO of BioVeris through to 2008 since 2008.
Age 59
Tenure 16 years
Professional MarksMBA
Phone617-225-2500
Webhttp://www.dyax.com
Migausky received a MBA from Babson College and a Bachelors of Science from Boston College.

Dyax Corp Management Efficiency

The company has return on total asset (ROA) of (0.06) % which means that it has lost $0.06 on every $100 spent on assets. This is way below average. Dyax Corp's management efficiency ratios could be used to measure how well Dyax Corp manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 82.17 M in liabilities with Debt to Equity (D/E) ratio of 0.26, which may suggest the company is not taking enough advantage from borrowing. Dyax Corp has a current ratio of 11.43, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Dyax Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Dyax Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Dyax Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Dyax to invest in growth at high rates of return. When we think about Dyax Corp's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 7 records

CFO Age

Erik AldagMinerals Technologies
39
Gina MastantuonoServiceNow
54
Michael ScarpelliServiceNow
51
Kelyn BrannonAsure Software
58
David NaimMicrobot Medical
48
Thomas CPABrandywine Realty Trust
62
Brad WolfeAsure Software
54
Dyax Corporation, a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema and other plasmakallikreinmediated disorders. Dyax Corp (DYAX) is traded on NASDAQ Exchange in USA and employs 124 people.

Management Performance

Dyax Corp Leadership Team

Elected by the shareholders, the Dyax Corp's board of directors comprises two types of representatives: Dyax Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dyax. The board's role is to monitor Dyax Corp's management team and ensure that shareholders' interests are well served. Dyax Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dyax Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Kempner, Independent Director
Henry Blair, Co-Founder, Chairman, Member of Strategy and Science Committee and Member of Compensation Committee
Jennifer Robinson, Associate Director, Investor Relations and Corporate Communications
James Fordyce, Independent Director
Marc Kozin, Independent Director
Mary Gray, Lead Independent Director
Paolo Pucci, Independent Director
George Migausky, CFO, Principal Accounting Officer and Executive VP
Andrew Ashe, Executive VP, General Counsel and Secretary
Abbie Celniker, Independent Director
Ron Cohen, Independent Director
Burt Adelman, Chief Medical Officer, Executive Vice President - Research and Development
Gustav Christensen, CEO and President and Director
Todd Bazemore, Executive Vice President and Chief Commercial Officer
David McLachlan, Independent Director

Dyax Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Dyax Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Dyax Corp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dyax Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyax Corp will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to BorgWarner could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BorgWarner when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BorgWarner - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BorgWarner to buy it.
The correlation of BorgWarner is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BorgWarner moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BorgWarner moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BorgWarner can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the Dyax Corp information on this page should be used as a complementary analysis to other Dyax Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Consideration for investing in Dyax Stock

If you are still planning to invest in Dyax Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dyax Corp's history and understand the potential risks before investing.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.